Peptide InjectionsAI
Emerging evidence

Cortagen

Peptide therapy: benefits, side effects, cost and protocols

C17H26N4O9

430.4 g/mol / CID 18439621
C17H26N4O9

Cortagen is a short bioregulatory peptide that targets the cerebral cortex. Developed as part of the Khavinson bioregulator peptide series, it is studied for its potential to normalize brain cortex function, improve cognitive performance, and support neurological health.

ByChris Riley(CFA)|Updated

Sources: FDA / PubMed / ClinicalTrials.gov View

FDA status
Research Only Not currently approved for human use in the US. Available as a research compound. Not eligible for compounding.
Evidence
Emerging Evidence

Who Cortagen is usually considered for

  • Cerebral cortex support
  • 2 preclinical studies
  • Neuroprotection
  • Cognitive function
  • Age-related brain support
  • 2 preclinical studies
  • Primarily animal or early-phase data

How Cortagen works

Bioregulator peptide that may interact with DNA promoter regions in cortical neurons, modulating gene expression related to neuronal survival and synaptic function.

Key studies

15 papers on PubMed / 2 human trials

  1. 01

    Effects of short peptides on lymphocyte chromatin in senile subjects

    Bull Exp Biol Med / Bull Exp Biol Med

  2. 02

    Short peptides alter lymphocyte chromatin structure in elderly subjects

  3. 03

    [Cortexin and cortagen as correcting agents in functional and metabolic disorders in the brain in chronic ischemia]

    Eksp Klin Farmakol / Eksp Klin Farmakol / Animal

  4. 04

    Cortexin and cortagen improved functional and metabolic brain disorders in chronic ischemia models

  5. 05

    Production of lymphocyte-activating factors by mouse macrophages during aging and under the effect of short peptides

  6. 06

    Gumen AV, Kozinets IA, Shanin SN et al

    Bull Exp Biol Med / Bull Exp Biol Med / Animal

  7. 07

    Short peptides modulated lymphocyte-activating factor production by macrophages during aging

  8. 08

    Synthesis of IL-2 mRNA in cells of rat hypothalamic structures after injection of short peptides

  9. 09

    Kazakova TB, Barabanova SV, Novikova NS et al

    Bull Exp Biol Med / Bull Exp Biol Med / Animal

  10. 10

    Short peptides increased IL-2 mRNA synthesis in rat hypothalamic structures

Cortagen compound data

C17H26N4O9
430.4 g/mol
18439621 ↗
(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-4-carboxy-butanoyl]amino]-3-carboxy-propanoyl]pyrrolidine-2-carboxylic acid

Cortagen questions

What is CORTAGEN?

Cortagen is a Khavinson bioregulator tripeptide researched for cerebral cortex support and neuroprotective activity in age-related cognitive decline.

How does CORTAGEN work?

Bioregulator peptide that may interact with DNA promoter regions in cortical neurons, modulating gene expression related to neuronal survival and synaptic function.

Is CORTAGEN legal to buy?

CORTAGEN is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.

Where can I buy CORTAGEN?

CORTAGEN is available as a research compound from verified online vendors. Always verify third-party testing before purchasing.

What category does CORTAGEN belong to?

CORTAGEN is primarily classified as a cognitive enhancement peptide. Nootropic peptides researched for cognitive function, memory, focus, neuroprotection, and neurogenesis.

What are the research benefits of CORTAGEN?

CORTAGEN has been studied for: Cerebral cortex support, Neuroprotection, Cognitive function, Age-related brain support. Khavinson bioregulator; brain/cerebral cortex focus.

Cortagen in the news

News aggregated via Google News. Inclusion does not imply endorsement.

Considering Cortagen?

The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.

Take the quiz